Related Experiment Video
Updated: Aug 15, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
MR imaging characteristics of noncancerous lesions of the prostate
K Lovett1, M D Rifkin, P A McCue
1Department of Radiology, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia.
Abstract:
Radical prostatectomy specimens from 53 men with clinical stage A or B prostate cancer were retrospectively reviewed and compared with correlative axial T2-weighted magnetic resonance (MR) images obtained just before surgery. Non-cancerous lesions were evaluated for signal intensity and location. Focal high-signal-intensity areas (n = 72) were present in 81% of patients. The 26% of lesions seen in the central gland all correlated with cystic atrophy. Of the 53 lesions seen in the peripheral prostate, 47 (89%) were cystic atrophy without associated cancer, four (7.5%) cystic atrophy with cancer, and two (3.8%) focal inflammation. Focal low-signal-intensity areas (n = 42) were present in 60% of patients. Of the 31% of lesions in the central prostate, one-fifth correlated with benign prostatic hyperplasia (BPH) and four-fifths with fibrous tissue. Of the 69% of peripheral lesions, 83% corresponded to fibrous tissue, 10% to BPH, and 7% to normal tissue. Mixed lesions (n = 42) were present in 64% of patients; 86% of these were located centrally and 14% peripherally. All mixed central lesions were BPH; the peripheral lesions were areas of combined cystic atrophy and fibrosis. BPH of low or mixed signal intensity can extend into the peripheral prostate and mimic cancer. High-intensity cystic atrophy associated with cancer can mimic normal tissue.
Insights
Magnetic resonance imaging (MRI) can help differentiate prostate cancer from benign conditions. T2-weighted MRI findings of cystic atrophy and benign prostatic hyperplasia (BPH) can mimic prostate cancer, requiring careful interpretation.
Area of Science:
- Radiology
- Uropathology
- Oncology
Background:
- Accurate differentiation between prostate cancer and benign prostatic conditions is crucial for effective treatment planning.
- Magnetic resonance imaging (MRI) is a key modality for evaluating prostate abnormalities.
Purpose of the Study:
- To correlate findings on axial T2-weighted MRI with radical prostatectomy specimens in patients with early-stage prostate cancer.
- To identify specific MRI signal intensities and locations associated with benign prostatic lesions that may mimic cancer.
Main Methods:
- Retrospective review of radical prostatectomy specimens from 53 men with clinical stage A or B prostate cancer.
- Correlation with pre-operative axial T2-weighted MRI findings, evaluating signal intensity and location of non-cancerous lesions.
Main Results:
- Focal high-signal-intensity areas (81% of patients) often represented cystic atrophy, with peripheral lesions correlating with cystic atrophy (with or without cancer) or inflammation.
- Focal low-signal-intensity areas (60% of patients) in the central gland correlated with benign prostatic hyperplasia (BPH) or fibrous tissue; peripheral lesions were predominantly fibrous tissue or BPH.
- Mixed signal-intensity lesions (64% of patients) were mostly central BPH or peripheral cystic atrophy with fibrosis.
Conclusions:
- Benign prostatic hyperplasia (BPH) with low or mixed signal intensity can mimic prostate cancer, especially when extending into the peripheral zone.
- High-intensity cystic atrophy associated with cancer can be mistaken for normal tissue on T2-weighted MRI.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Ultrasonography
During an ultrasonography procedure, a handheld device called a...
Imaging Studies II: Ultrasonography
Imaging Studies III: Computed Tomography
Imaging Studies IV: Magnetic Resonance Imaging

